{
    "Trade/Device Name(s)": [
        "illumigene\u00ae Mycoplasma DNA Amplification Assay",
        "illumigene\u00ae Mycoplasma External Controls"
    ],
    "Submitter Information": "Meridian Bioscience, Inc.",
    "510(k) Number": "K123423",
    "Predicate Device Reference 510(k) Number(s)": [
        "K120267"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZX",
        "OOI"
    ],
    "Summary Letter Date": "May 22, 2013",
    "Summary Letter Received Date": "May 23, 2013",
    "Submission Date": "May 30, 2013",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Mycoplasma pneumoniae DNA"
    ],
    "Specimen Type(s)": [
        "Throat swab",
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Rayon swab",
        "Polyester swab",
        "M4 transport medium"
    ],
    "Instrument(s)/Platform(s)": [
        "illumipro-10\u2122 Automated Isothermal Amplification and Detection System"
    ],
    "Method(s)/Technology(ies)": [
        "Loop-mediated isothermal amplification (LAMP)",
        "DNA amplification",
        "Visible light transmission detection"
    ],
    "Methodologies": [
        "Qualitative in vitro DNA detection",
        "Isothermal amplification"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for illumigene\u00ae Mycoplasma DNA Amplification Assay, a qualitative isothermal amplification test for Mycoplasma pneumoniae DNA in throat and nasopharyngeal swabs using the illumipro-10\u2122 system.",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test for direct detection of Mycoplasma pneumoniae DNA in human throat and nasopharyngeal swabs from patients suspected of Mycoplasma pneumoniae infection; for use with the illumipro-10 system and intended for point-of-care use.",
    "fda_folder": "Microbiology"
}